Target Entity
Name: Davaindia Health Mart Limited
Type of Deal
Investment via subscription to a rights issue in a wholly-owned subsidiary.
Stake/Capacity
The Company acquired 39,228 equity shares. Post this acquisition, Davaindia Health Mart Limited continues to remain the wholly-owned subsidiary (WOS) of Zota Health Care Limited.
Deal Value
The total cost of acquisition for 39,228 equity shares is ₹19,90,82,100.00 (Nineteen Crore Ninety Lakh Eighty-Two Thousand One Hundred Only). The price per share is ₹5,075.00, which includes a premium of ₹5,065.00 per equity share.
Funding Source
The consideration was paid in cash.
Financial Impact
The investment is intended to mitigate the working capital requirements of the subsidiary, Davaindia Health Mart Limited. The document does not disclose specific projected financial impacts such as revenue contribution, EBITDA impact, or accretion/dilution.
Timeline
The acquisition was completed on October 01, 2026.
Strategic Rationale
The investment is described as a strategic investment. The primary stated objects are to support the subsidiary's working capital requirements.
Approval Status
The transaction is completed. No governmental or regulatory approvals were required for this acquisition (N.A.).
Reference Regulation
Background on Target Entity
Name: Davaindia Health Mart Limited
Business: Operates a retail generic pharmacy chain under a Company Owned Company Operated (COCO) model. It offers 2000+ SKUs inclusive of Medicines, Ayurvedic, Cosmetics, Nutraceutical, and OTC products.
Date of Incorporation: January 01, 2020
Country of Presence: India
Store Presence: 23 states and 5 Union Territories with 1855 stores as of June 30, 2026.
Financial History (Turnover):
- FY 2023-24: ₹44.77 crores
- FY 2024-25: ₹109.93 crores
- FY 2025-26: ₹267.71 crores
Current Paid-up Share Capital: ₹298.13 lakhs
Related Party Transaction
The acquisition does not fall within the ambit of related party transactions. The promoter/promoter group/group companies do not have any interest in the WOS, and the transaction was conducted on an arm's length basis.